← All stories
Health, Longevity & Biohacking

Richard Louis Miller alleges big pharma routinely obscures adverse-effects data

By Egleze Editorial Desk · Published August 10, 2026 · Third Wave Podcast · Psychedelic Medicine’s Biggest Blind Spots | Richard Louis Miller
Richard Louis Miller alleges big pharma routinely obscures adverse-effects data
Third Wave Podcast
Third Wave Podcast
Psychedelic Medicine’s Biggest Blind Spots | Richard Louis Miller

What was said

""One is big pharma does not reveal all of their adverse effects. They hide a lot of their adverse effects in the same way that the presidents of the major cigarette companies in the United States got up before Congress.""

Clinical psychologist Richard Louis Miller argues that psychedelic medicine needs to be more transparent about harms, because, he claims, pharmaceutical companies have a history of downplaying adverse effects. He cites historic examples including tobacco executives’ testimony to Congress and later claims about opioid addiction, framing these as warnings for how public trust can be undermined.

Verification status

Attributed speaker claim

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Source and context

Egleze verified who said this and where. The underlying claim has not been independently established by Egleze.

Programme
Third Wave Podcast
Episode
Psychedelic Medicine’s Biggest Blind Spots | Richard Louis Miller
Clip time
2:26
Original source
Watch the source segment →
From this episode
Third Wave Podcast
Third Wave Podcast

Psychedelic Medicine’s Biggest Blind Spots | Richard Louis Miller

August 10, 2026 · 44m · 2 Egleze moments
Read episode summary and key points →

More moments from this episode

Health, Longevity & BiohackingMiller says cardiovascular risks should shape who takes psychedelic treatments→
More stories More from Third Wave Podcast